Literature DB >> 18292239

Nuclear receptor location analyses in mammalian genomes: from gene regulation to regulatory networks.

Geneviève Deblois1, Vincent Giguère.   

Abstract

Rapid progress in mapping nuclear receptor binding sites, referred to as "location analysis," has recently been achieved through the use of chromatin immunoprecipitation approaches. Location analysis can be performed on a single locus or cover a complete genome, and the resulting datasets can be probed to identify direct target genes and/or investigate the molecular mechanisms by which nuclear receptors control gene expression. In addition, when coupled with other genetic and functional genomics investigative methods, location analysis has proven to be a powerful tool with which to identify novel biological functions of nuclear receptors and build transcriptional regulatory networks. Thus, the knowledge gained from several recent chromatin immunoprecipitation-based studies has challenged basic concepts of nuclear receptor action, offered new insights into gene-regulatory mechanisms, and led to the identification of nuclear receptor-controlled biological functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292239      PMCID: PMC5419453          DOI: 10.1210/me.2007-0546

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  74 in total

1.  Genome-wide location and function of DNA binding proteins.

Authors:  B Ren; F Robert; J J Wyrick; O Aparicio; E G Jennings; I Simon; J Zeitlinger; J Schreiber; N Hannett; E Kanin; T L Volkert; C J Wilson; S P Bell; R A Young
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

2.  Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping interactions between genomic elements.

Authors:  Josée Dostie; Todd A Richmond; Ramy A Arnaout; Rebecca R Selzer; William L Lee; Tracey A Honan; Eric D Rubio; Anton Krumm; Justin Lamb; Chad Nusbaum; Roland D Green; Job Dekker
Journal:  Genome Res       Date:  2006-09-05       Impact factor: 9.043

3.  Genome-wide analysis of estrogen receptor binding sites.

Authors:  Jason S Carroll; Clifford A Meyer; Jun Song; Wei Li; Timothy R Geistlinger; Jérôme Eeckhoute; Alexander S Brodsky; Erika Krasnickas Keeton; Kirsten C Fertuck; Giles F Hall; Qianben Wang; Stefan Bekiranov; Victor Sementchenko; Edward A Fox; Pamela A Silver; Thomas R Gingeras; X Shirley Liu; Myles Brown
Journal:  Nat Genet       Date:  2006-10-01       Impact factor: 38.330

4.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

5.  Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters.

Authors:  Alfred S L Cheng; Victor X Jin; Meiyun Fan; Laura T Smith; Sandya Liyanarachchi; Pearlly S Yan; Yu-Wei Leu; Michael W Y Chan; Christoph Plass; Kenneth P Nephew; Ramana V Davuluri; Tim H-M Huang
Journal:  Mol Cell       Date:  2006-02-03       Impact factor: 17.970

6.  Interaction of the glucocorticoid receptor with the chromatin landscape.

Authors:  Sam John; Peter J Sabo; Thomas A Johnson; Myong-Hee Sung; Simon C Biddie; Stafford L Lightman; Ty C Voss; Sean R Davis; Paul S Meltzer; John A Stamatoyannopoulos; Gordon L Hager
Journal:  Mol Cell       Date:  2008-03-14       Impact factor: 17.970

7.  Estradiol regulation of the human retinoic acid receptor alpha gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs.

Authors:  A K Rishi; Z M Shao; R G Baumann; X S Li; M S Sheikh; S Kimura; N Bashirelahi; J A Fontana
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

8.  The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload.

Authors:  Janice M Huss; Ken-ichi Imahashi; Catherine R Dufour; Carla J Weinheimer; Michael Courtois; Atilla Kovacs; Vincent Giguère; Elizabeth Murphy; Daniel P Kelly
Journal:  Cell Metab       Date:  2007-07       Impact factor: 27.287

9.  Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defense.

Authors:  Junichiro Sonoda; Josée Laganière; Isaac R Mehl; Grant D Barish; Ling-Wa Chong; Xiangli Li; Immo E Scheffler; Dennis C Mock; Alain R Bataille; Francois Robert; Chih-Hao Lee; Vincent Giguère; Ronald M Evans
Journal:  Genes Dev       Date:  2007-08-01       Impact factor: 11.361

Review 10.  Mammalian RNA polymerase II core promoters: insights from genome-wide studies.

Authors:  Albin Sandelin; Piero Carninci; Boris Lenhard; Jasmina Ponjavic; Yoshihide Hayashizaki; David A Hume
Journal:  Nat Rev Genet       Date:  2007-05-08       Impact factor: 53.242

View more
  21 in total

1.  Identification of direct forkhead box O1 targets involved in palmitate-induced apoptosis in clonal insulin-secreting cells using chromatin immunoprecipitation coupled to DNA selection and ligation.

Authors:  H Y Lin; Y Yin; J X Zhang; H Xuan; Y Zheng; S S Zhan; Y X Zhu; X Han
Journal:  Diabetologia       Date:  2012-07-20       Impact factor: 10.122

2.  The estrogen receptor α colocalizes with proopiomelanocortin in hypothalamic neurons and binds to a conserved motif present in the neuron-specific enhancer nPE2.

Authors:  Flávio S J de Souza; Sofia Nasif; Rodrigo López-Leal; Diego H Levi; Malcolm J Low; Marcelo Rubinsten
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

3.  The rules of DNA recognition by the androgen receptor.

Authors:  Sarah Denayer; Christine Helsen; Lieven Thorrez; Annemie Haelens; Frank Claessens
Journal:  Mol Endocrinol       Date:  2010-03-19

4.  Physiological genomics identifies estrogen-related receptor alpha as a regulator of renal sodium and potassium homeostasis and the renin-angiotensin pathway.

Authors:  Annie M Tremblay; Catherine R Dufour; Majid Ghahremani; Timothy L Reudelhuber; Vincent Giguère
Journal:  Mol Endocrinol       Date:  2009-11-09

5.  Genome-wide analysis of binding sites and direct target genes of the orphan nuclear receptor NR2F1/COUP-TFI.

Authors:  Celina Montemayor; Oscar A Montemayor; Alex Ridgeway; Feng Lin; David A Wheeler; Scott D Pletcher; Fred A Pereira
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

6.  Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism.

Authors:  Suneil K Koliwad; Taiyi Kuo; Lauren E Shipp; Nora E Gray; Fredrik Backhed; Alex Yick-Lun So; Robert V Farese; Jen-Chywan Wang
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

Review 7.  Feed-forward transcriptional programming by nuclear receptors: regulatory principles and therapeutic implications.

Authors:  Sarah K Sasse; Anthony N Gerber
Journal:  Pharmacol Ther       Date:  2014-08-25       Impact factor: 12.310

8.  Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver.

Authors:  Linda M Sanderson; Tatjana Degenhardt; Arjen Koppen; Eric Kalkhoven; Beatrice Desvergne; Michael Müller; Sander Kersten
Journal:  Mol Cell Biol       Date:  2009-10-05       Impact factor: 4.272

9.  Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation.

Authors:  Timothy E Reddy; Florencia Pauli; Rebekka O Sprouse; Norma F Neff; Kimberly M Newberry; Michael J Garabedian; Richard M Myers
Journal:  Genome Res       Date:  2009-10-02       Impact factor: 9.043

10.  HRTBLDb: an informative data resource for hormone receptors target binding loci.

Authors:  Brian A Kennedy; Wenqing Gao; Tim H-M Huang; Victor X Jin
Journal:  Nucleic Acids Res       Date:  2009-09-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.